Correlation Between Cantargia and Xbrane Biopharma
Can any of the company-specific risk be diversified away by investing in both Cantargia and Xbrane Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cantargia and Xbrane Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cantargia AB and Xbrane Biopharma AB, you can compare the effects of market volatilities on Cantargia and Xbrane Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cantargia with a short position of Xbrane Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cantargia and Xbrane Biopharma.
Diversification Opportunities for Cantargia and Xbrane Biopharma
0.67 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Cantargia and Xbrane is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Cantargia AB and Xbrane Biopharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xbrane Biopharma and Cantargia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cantargia AB are associated (or correlated) with Xbrane Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xbrane Biopharma has no effect on the direction of Cantargia i.e., Cantargia and Xbrane Biopharma go up and down completely randomly.
Pair Corralation between Cantargia and Xbrane Biopharma
Assuming the 90 days trading horizon Cantargia AB is expected to generate 0.59 times more return on investment than Xbrane Biopharma. However, Cantargia AB is 1.71 times less risky than Xbrane Biopharma. It trades about 0.17 of its potential returns per unit of risk. Xbrane Biopharma AB is currently generating about 0.02 per unit of risk. If you would invest 167.00 in Cantargia AB on October 25, 2024 and sell it today you would earn a total of 11.00 from holding Cantargia AB or generate 6.59% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 94.12% |
| Values | Daily Returns |
Cantargia AB vs. Xbrane Biopharma AB
Performance |
| Timeline |
| Cantargia AB |
| Xbrane Biopharma |
Cantargia and Xbrane Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cantargia and Xbrane Biopharma
The main advantage of trading using opposite Cantargia and Xbrane Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cantargia position performs unexpectedly, Xbrane Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xbrane Biopharma will offset losses from the drop in Xbrane Biopharma's long position.| Cantargia vs. Hansa Biopharma AB | Cantargia vs. Oncopeptides AB | Cantargia vs. BioArctic AB | Cantargia vs. Alligator Bioscience AB |
| Xbrane Biopharma vs. Hansa Biopharma AB | Xbrane Biopharma vs. Vicore Pharma Holding | Xbrane Biopharma vs. XSpray Pharma AB | Xbrane Biopharma vs. Saniona AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |